Logo

Eh, Everybody's Broke These Days

Apr 01, 2009

Science Insider reports that DeCode Genetics only has enough cash to make it to the summer. The company lost millions of dollars when Lehman Brothers, which managed its finances, went bankrupt, though it was later able to sell some of those securities. Even as CEO Kári Stefánsson says DeCode is in "a very tough spot," the company is optimistic as it restructures its debt and re-emphasizes its diagnostic tests.

Filed under

Diagnostics
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.